Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

STIM'ZO : Examining tDCS as an add-on Treatment for Persistent Symptoms in Schizophrenia (SCH)

NCT02744989 is registered in ClinicalTrials.gov with Hospices Civils de Lyon as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02744989 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
STIM'ZO : Examining tDCS as an add-on Treatment for Persistent Symptoms in Schizophrenia (SCH)
Lead sponsor
Hospices Civils de Lyon
Phase
Not applicable
Overall status
Completed
Start date
May 30, 2016
Completion date
October 19, 2022
Enrollment
141 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.